35 results
Page 2 of 2
6-K
EX-99
dp2e7bo1tp xdq
17 Mar 14
BioLineRx Reports Year End 2013 Financial Results
12:00am
6-K
EX-99
cjpm1zpkv 3ehn
8 Jan 14
Current report (foreign)
12:00am
424B3
6ltkx j3pp6t6ail0
8 Aug 13
Prospectus supplement
12:00am
424B3
uwgcct
15 Oct 12
Prospectus supplement
12:00am
F-1
jsmbfdue4h6rnx 3lf
2 Oct 12
Registration statement (foreign)
12:00am
424B3
vj9t06
28 Mar 12
Prospectus supplement
12:00am
20-F
1ki 9b8rvp
22 Mar 12
Annual report (foreign)
12:00am
6-K
EX-99
nqgdtzn
28 Nov 11
BioLineRx Reports Third Quarter 2011 Financial Results
12:00am
6-K
EX-99
tcqd5par9 wru7v
28 Nov 11
BioLineRx Reports Third Quarter 2011 Financial Results
12:00am
6-K
EX-1
hoi7myg2wv0xx8x9u
6 Sep 11
Orally-Available Molecule for the Treatment of
12:00am
6-K
EX-2
kmzry13 3325p7g
23 Aug 11
Condensed Consolidated Interim Financial Statements
12:00am
20FR12B/A
2gor4kc9
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
dubfi6q 5ndmxtho0qrx
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
4vbtngl4ui8x9n yop91
24 Sep 10
Registration statement (foreign)
12:00am